Affiliation:
1. Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University
Publisher
International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine
Reference12 articles.
1. 1. Vogt T, Brockmeyer N, Kutzner H, Schofer H. Brief s1 guidelines-cutaneous angiosarcoma and kaposi sarcoma. J Dtsch Dermatol Ges. 2013; 11:(Suppl 3):2-9, 2-10.
2. 2. Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D, Kelsen DP, Schwartz GK, Casper ES. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999; 86:2034-2037.
3. 3. Penel N, Bui BN, Bay JO, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: The angiotax study. J Clin Oncol. 2008; 26:5269-5274.
4. 4. Nagano T, Yamada Y, Ikeda T, Kanki H, Kamo T, Nishigori C. Docetaxel: A therapeutic option in the treatment of cutaneous angiosarcoma: Report of 9 patients. Cancer. 2007; 110:648-651.
5. 5. Fujisawa Y, Yoshino K, Kadono T, Miyagawa T, Nakamura Y, Fujimoto M. Chemoradiotherapy with taxane was superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: Multi-center, retrospective study. Br J Dermatol. 2014; 171:1493-1500.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献